Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

The laser comb did not improve hair regrowth in mice with alopecia areata.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

The girl's regrown brown hair had less of certain pigments than her original black hair.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

People with alopecia areata often have lower vitamin D levels than healthy people.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Prachchhana Karma and Ayurvedic medication can help treat patchy hair loss.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

The SBN system effectively assesses alopecia areata severity and predicts its course.